Description: Valeant Pharmaceuticals said on Monday that it was willing to raise its offer for the Botox maker Allergan, and once again invited the company to negotiate a friendly deal.
Date: Oct 27, 2014
Questions for Discussions:
- What will the affect of a $200 offer be on both firms’ stock values?
- Do you think the strategy of publically offering this price is a correct one?